[go: up one dir, main page]

SE0203687D0 - Pharmaceutical Porous Particles - Google Patents

Pharmaceutical Porous Particles

Info

Publication number
SE0203687D0
SE0203687D0 SE0203687A SE0203687A SE0203687D0 SE 0203687 D0 SE0203687 D0 SE 0203687D0 SE 0203687 A SE0203687 A SE 0203687A SE 0203687 A SE0203687 A SE 0203687A SE 0203687 D0 SE0203687 D0 SE 0203687D0
Authority
SE
Sweden
Prior art keywords
pharmaceutical
porous particles
sup
particle
porous
Prior art date
Application number
SE0203687A
Other languages
English (en)
Inventor
Ian Harwigsson
Original Assignee
Ian Harwigsson Med Adagit Fa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ian Harwigsson Med Adagit Fa filed Critical Ian Harwigsson Med Adagit Fa
Priority to SE0203687A priority Critical patent/SE0203687D0/sv
Publication of SE0203687D0 publication Critical patent/SE0203687D0/sv
Priority to JP2005508295A priority patent/JP2006511617A/ja
Priority to CA002509216A priority patent/CA2509216A1/en
Priority to AU2003287132A priority patent/AU2003287132B2/en
Priority to PCT/SE2003/001952 priority patent/WO2004054556A1/en
Priority to EP03781201A priority patent/EP1569626A1/en
Priority to US11/149,927 priority patent/US20060002995A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE0203687A 2002-12-13 2002-12-13 Pharmaceutical Porous Particles SE0203687D0 (sv)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE0203687A SE0203687D0 (sv) 2002-12-13 2002-12-13 Pharmaceutical Porous Particles
JP2005508295A JP2006511617A (ja) 2002-12-13 2003-12-15 製薬用多孔質粒子
CA002509216A CA2509216A1 (en) 2002-12-13 2003-12-15 Pharmaceutical porous particles
AU2003287132A AU2003287132B2 (en) 2002-12-13 2003-12-15 Pharmaceutical porous particles
PCT/SE2003/001952 WO2004054556A1 (en) 2002-12-13 2003-12-15 Pharmaceutical porous particles
EP03781201A EP1569626A1 (en) 2002-12-13 2003-12-15 Pharmaceutical porous particles
US11/149,927 US20060002995A1 (en) 2002-12-13 2005-06-10 Pharmaceutical porous particles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0203687A SE0203687D0 (sv) 2002-12-13 2002-12-13 Pharmaceutical Porous Particles

Publications (1)

Publication Number Publication Date
SE0203687D0 true SE0203687D0 (sv) 2002-12-13

Family

ID=20289848

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0203687A SE0203687D0 (sv) 2002-12-13 2002-12-13 Pharmaceutical Porous Particles

Country Status (2)

Country Link
US (1) US20060002995A1 (sv)
SE (1) SE0203687D0 (sv)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006028916B4 (de) * 2006-06-23 2015-07-16 Robert Bosch Gmbh Verfahren zur Herstellung poröser Partikel
BRPI1011836A2 (pt) * 2009-04-21 2017-05-16 Selecta Biosciences Inc imunonanoterapêuticos que fornecem uma resposta induzida por th1
CN102481375B (zh) * 2009-05-27 2017-06-06 西莱克塔生物科技公司 具有不同释放速率的纳米载体加工组分
JP6324067B2 (ja) 2010-05-26 2018-05-16 セレクタ バイオサイエンシーズ インコーポレーテッドＳｅｌｅｃｔａ Ｂｉｏｓｃｉｅｎｃｅｓ，Ｉｎｃ． 多価合成ナノキャリアワクチン
KR20140050698A (ko) 2011-07-29 2014-04-29 셀렉타 바이오사이언시즈, 인크. 체액성 및 세포독성 t 림프구(ctl) 면역 반응을 발생시키는 합성 나노운반체
US9757529B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9757395B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
WO2014178891A1 (en) 2013-04-30 2014-11-06 Otitopic Inc. Dry powder formulations and methods of use
CA2938996A1 (en) 2014-02-10 2015-08-13 Patara Pharma, LLC Methods for the treatment of lung diseases with mast cell stabilizers
PT3104853T (pt) 2014-02-10 2020-01-14 Respivant Sciences Gmbh Tratamento com estabilizadores de mastócitos para distúrbios sistémicos
EP3331522A1 (en) 2015-08-07 2018-06-13 Patara Pharma LLC Methods for the treatment of mast cell related disorders with mast cell stabilizers
US10265296B2 (en) 2015-08-07 2019-04-23 Respivant Sciences Gmbh Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
JP2019528320A (ja) 2016-08-31 2019-10-10 レシュピファント サイエンシス ゲゼルシャフト ミット ベシュレンクター ハフトゥングＲｅｓｐｉｖａｎｔ Ｓｃｉｅｎｃｅｓ Ｇｍｂｈ 特発性肺線維症による慢性咳の治療のためのクロモリン組成物
EP3522983A4 (en) 2016-10-07 2020-06-03 Respivant Sciences GmbH CROMOLYNE-BASED COMPOSITIONS FOR THE TREATMENT OF PULMONARY FIBROSIS
CN115919780A (zh) 2017-09-22 2023-04-07 维克图拉公司 含有硬脂酸镁的干粉组合物
US10786456B2 (en) 2017-09-22 2020-09-29 Otitopic Inc. Inhaled aspirin and magnesium to treat inflammation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5456917A (en) * 1993-04-12 1995-10-10 Cambridge Scientific, Inc. Method for making a bioerodible material for the sustained release of a medicament and the material made from the method
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US20020017295A1 (en) * 2000-07-07 2002-02-14 Weers Jeffry G. Phospholipid-based powders for inhalation
US6309623B1 (en) * 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers

Also Published As

Publication number Publication date
US20060002995A1 (en) 2006-01-05

Similar Documents

Publication Publication Date Title
SE0203687D0 (sv) Pharmaceutical Porous Particles
DE60217367D1 (de) Nanopartikelzusammensetzungen enthaltend insulin
EP1226104A4 (en) PHENOXY CARBOXYLIC ACID COMPOUNDS AND COMPOSITIONS USED TO DIFFUSER ACTIVE AGENTS
DE60334924D1 (de) Anoteilchengrösse
HK1052553A1 (zh) 膠原酶的溶液和晶格及其使用
BR0107565A (pt) Formas de dosagem de benzimidazol substituìdo e método de emprego das mesmas
ITMI20002099A0 (it) Metodo per la produzione di dispositivi getter porosi con ridotta perdita di particelle e dispositivi cosi' prodotti
ATE355829T1 (de) Einen lipophilen wirkstoff enthaltende feste pharmazeutische zusammensetzung sowie deren herstellung
NO20010531D0 (no) Medisinske aerosolformuleringer
DK1372608T3 (da) Medicinske aerosolformuleringer
EP1708686A4 (en) GENERAL LINEAR SHELL FORM OF FENTANYL FOR ORAL USE AND METHOD OF ADMINISTRATION
JP2004515500A5 (sv)
ATE506066T1 (de) Zusammensetzungen aus hypotensivem lipid (prostaglandin) und timolol sowie deren verwendungszwecke
ATE316815T1 (de) Kohlenstoffblock-wasserfilter
DK1318788T3 (da) Nanopartikulær fastdosissammensætninger
TR200002796T2 (tr) Aminosikloheksil eter bileşikleri ve bunların kullanımları.
DK1459737T3 (da) Granulat indeholdende syreustabilt kemisk middel i stor mængde
AR040177A1 (es) Sal de formiato de o-desmetil-venlafaxina
DE60108154D1 (de) Pharmazeutische Zubereitungen enthaltend Clavulansäure
SE0302573D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
CY1105247T1 (el) Υποκατεστημενα παραγωγα c- κυκλοεξυλομεθυλαμινης
MA26346A1 (fr) Compositions de preparation contenant des composes actifs au plan physiologique et instables aux acides et leur procede de production.
CY1107230T1 (el) Υποκατεστημενες ενωσεις 1-φαιναιθυλοπιπεριδινης, οι οποιες μεταξυ αλλων χρησιμοποιουνται σαν αναλγητικα
UY27587A1 (es) Heterociclos terapéuticos